Ichii, Mitsuru
Mori, Katsuhito
Miyaoka, Daichi
Sonoda, Mika
Tsujimoto, Yoshihiro
Nakatani, Shinya
Shoji, Tetsuo
Emoto, Masanori
Article History
Received: 30 August 2020
Accepted: 10 March 2021
First Online: 20 March 2021
Declarations
:
: Not applicable.
: Written informed consent for publication was obtained from the present patient. A copy of the written consent is available for review by the Editor of this journal.
: MI received an honorarium for lecturing from Astellas Pharma Inc. and Kyowa Kirin Co., Ltd. KM received an honorarium for lecturing from Astellas Pharma Inc., Mitsubishi Tanabe Pharma Corporation and Kyowa Kirin Co., Ltd. YT received an honorarium for lecturing from Astellas Pharma Inc. and Kyowa Kirin Co., Ltd. SN received an honorarium for lecturing from Kyowa Kirin Co., Ltd. ME received an honorarium for lecturing from Astellas Pharma Inc., Mitsubishi Tanabe Pharma Corporation and Kyowa Kirin Co., Ltd. DM, MS, and TS have no conflict of interest.